Roy Navon

5.4k citations

20 papers · 3.2k indexed · 1 hit paper · h-index 10

Impact in

Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Aging top 5%

Papers in ⓘ

Molecular Biology 12
- Gene expression and cancer classification 5
- RNA Research and Splicing 3
- Bioinformatics and Genomic Networks 3
Cancer Research 6
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 6

Co-authors: Zohar Yakhini (11 shared papers)Israel Steinfeld (8 shared papers)Eran Eden (8 shared papers)Doron Lipson (2 shared papers)Anya Tsalenko (2 shared papers)Hui Wang (1 shared paper)Amir Ben‐Dor (1 shared paper)Anne‐Lise Børresen‐Dale (2 shared papers)
Journals: PLoS ONE (5 papers)Open Forum Infectious Diseases (3 papers)BMC Bioinformatics (2 papers)Bioinformatics (2 papers)Molecular Oncology (1 paper)
Partner nations: Israel United States Switzerland

In The Last Decade

Roy Navon

18 papers receiving 3.1k citations

Hit Papers

align trajectories log scale

GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists 2009 · 2.4k citations

Peers

Countries citing papers authored by Roy Navon

Since Specialization

Citations

This map shows the geographic impact of Roy Navon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Navon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Navon more than expected).

Fields of papers citing papers by Roy Navon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy Navon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Navon. The network helps show where Roy Navon may publish in the future.

Co-authors

The 25 scholars most cited alongside Roy Navon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roy Navon Line = papers co-authored together Roy Navon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists BMC Bioinformatics ·Eran Eden, Roy Navon, Israel Steinfeld, Doron Lipson, Zohar Yakhini Hit paper breakdown →	2009	2429
2	miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors PLoS ONE ·Espen Enerly, Israel Steinfeld, Kristine Kleivi Sahlberg, Suvi‐Katri Leivonen, Miriam R. R. Aure, Hege G. Russnes, Jo Anders Rønneberg, Hilde Johnsen, Roy Navon, Einar Andreas Rødland, Rami Mäkelä, Bjørn Naume, Merja Perälä, Olli Kallioniemi, Vessela N. Kristensen, Zohar Yakhini, Anne‐Lise Børresen‐Dale	2011	245
3	Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer Types PLoS ONE ·Roy Navon, Hui Wang, Israel Steinfeld, Anya Tsalenko, Amir Ben‐Dor, Zohar Yakhini	2009	147
4	Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor Molecular Cancer ·Liron Zehavi, Roi Avraham, Aviv Barzilai, Dalia Bar-Ilan, Roy Navon, Yechezkel Sidi, Dror Avni, Raya Leibowitz‐Amit	2012	114
5	A host-protein signature is superior to other biomarkers for differentiating between bacterial and viral disease in patients with respiratory infection and fever without source: a prospective observational study European Journal of Clinical Microbiology & Infectious Diseases ·Liat Ashkenazi‐Hoffnung, Kfir Oved, Roy Navon, Tom Friedman, Olga Boico, Meital Paz, Gali Kronenfeld, Liat Etshtein, Asi Cohen, Tanya Gottlieb, Eran Eden, Irina Chistyakov, Isaac Srugo, Adi Klein, Shai Ashkenazi, Oded Scheuerman	2018	56
6	A Novel Translocation Breakpoint within the BPTF Gene Is Associated with a Pre-Malignant Phenotype PLoS ONE ·Yosef Buganim, Ido Goldstein, Doron Lipson, Michael Milyavsky, Sylvie Polak‐Charcon, Corine Mardoukh, Hilla Solomon, Eyal Kalo, Shalom Madar, Ran Brosh, Marina Perelman, Roy Navon, Naomi Goldfinger, Iris Barshack, Zohar Yakhini, Varda Rotter	2010	49
7	miRNA target enrichment analysis reveals directly active miRNAs in health and disease Nucleic Acids Research ·Israel Steinfeld, Roy Navon, Robert A. Ach, Zohar Yakhini	2012	44
8	Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue Molecular Oncology ·Eldrid Borgan, Roy Navon, Hans Kristian Moen Vollan, Ellen Schlichting, Torill Sauer, Zohar Yakhini, Ole Christian Lingjærde, Thérese Sørlie, Anne‐Lise Børresen‐Dale	2011	25
9	Clinically driven semi-supervised class discovery in gene expression data Bioinformatics ·Israel Steinfeld, Roy Navon, Diego Ardigò, Ivana Zavaroni, Zohar Yakhini	2008	15
10	ENViz: a Cytoscape App for integrated statistical analysis and visualization of sample-matched data with multiple data types Bioinformatics ·Israel Steinfeld, Roy Navon, Michael Creech, Zohar Yakhini, Anya Tsalenko	2015	10
11	Host biomarkers and combinatorial scores for the detection of serious and invasive bacterial infection in pediatric patients with fever without source PLoS ONE ·Laurence Lacroix, Sebastien Papis, Chiara Mardegan, Fanny Luterbacher, Arnaud G. L’Huillier, Cyril Sahyoun, Kristina Keitel, Niv Mastboim, Liat Etshtein, Liran Shani, Einav Simon, Eran Barash, Roy Navon, Tanya Gottlieb, Kfir Oved, Eran Eden, Christophe Combescure, Annick Galetto-Lacour, Alain Gervaix	2023	9
12	Differential Serum and Urine CRP, IP-10, and TRAIL Levels in Pediatric Urinary Tract Infection Frontiers in Pediatrics ·Liat Ashkenazi‐Hoffnung, Gilat Livni, Oded Scheuerman, Itay Berger, Eran Eden, Kfir Oved, Liran Shani, Gali Kronenfeld, Einav Simon, Olga Boico, Roy Navon, Tanya Gottlieb, Eran Barash, Meital Paz, Yael Yuhas, Eva Berent, Shai Ashkenazi	2021	8
13	Semi-supervised class discovery using quantitative phenotypes – CVD as a case study BMC Bioinformatics ·Israel Steinfeld, Roy Navon, Diego Ardigò, Ivana Zavaroni, Zohar Yakhini	2007	4
14	A steroid metabolomic approach to 17α-hydroxylase/17,20 lyase deficiency Metabolomics ·Dov Tiosano, Roy Navon, Oshrat Flor, Carlos Knopf, Michaela F. Hartmann, Stefan A. Wudy, Zohar Yakhini, Ze’ev Hochberg	2010	3
15	Correction: miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors PLoS ONE ·Espen Enerly, Israel Steinfeld, Kristine Kleivi Sahlberg, Suvi‐Katri Leivonen, Miriam R. R. Aure, Hege G. Russnes, Jo Anders RÃ ̧nneberg, Hilde Johnsen, Roy Navon, Einar RÃ ̧dland, Rami Mäkelä, BjĂ ̧Rn Naume, Merja Perälä, Olli Kallioniemi, Vessela N. Kristensen, Zohar Yakhini, Anne-Lise BĂ ̧Rresen-Dale	2013	1
16	Growth Failure Associated with the Use of High Dose Prozac (Fluoxetine Hydrochloride) in a Patient with Type 1 Diabetes Mellitus Journal of Pediatric Endocrinology and Metabolism ·Graeme R. Frank, Roy Navon	1999	1
17	2624. Viral Pneumonia in Children: Facing the Challenge Using the Host Response Open Forum Infectious Diseases ·Niv Mastboim, Tanya Gottlieb, Isaac Srugo, Alain Gervaix, Meital Paz, Roy Navon, Olga Boico, Ellen Bamberger, Adi Klein, Michal Stein, Irina Chistyakov, Kfir Oved, Eran Eden, Liran Shani	2019	1
18	A Novel Host-protein Assay Accurately Distinguishes Bacterial From Viral Upper Respiratory Tract Infections Open Forum Infectious Diseases ·Kfir Oved, Eran Eden, Chantal B. van Houten, Tanya Gottlieb, Roy Navon, Asi Cohen, Olga Boico, Meital Paz, Liat Etshtein, Gali Kronenfeld, Tom Friedman, Ellen Bamberger, Irina Chistyakov, Israel Potasman, Michal Stein, Adi Klein, Alain Gervaix, Isaac Srugo, Louis Bont	2017	1
19	Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Protein as a Marker for Disease Severity in Patients With Acute Infection Open Forum Infectious Diseases ·Kfir Oved, Asi Cohen, Olga Boico, Roy Navon, Tom Friedman, Liat Etshtein, Ellen Bamberger, Ester Pri-Or, Tanya Gottlieb, Meital Paz, Isaac Srugo, Irina Chistyakov, Adi Klein, Israel Potasman, Eran Eden	2016	0
20	Automating a New Host-Protein Assay for Differentiating Bacterial from Viral Infection to Reduce Operator Hands-On Time BioTechniques ·Maanit Shapira, Olga Boico, Asi Cohen, Ruth Sagi, Ada Aharon, Roy Navon, Gali Kronenfeld, Katie Maler, Ester Pri-Or, Michal Stein, Adi Klein, Eran Eden, Kfir Oved	2018	0

About Roy Navon

Roy Navon is a scholar working on Molecular Biology, Cancer Research, Epidemiology, Clinical Biochemistry and Infectious Diseases, having authored 20 papers that have together received 3.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers), Gene expression and cancer classification (5 papers), Bacterial Identification and Susceptibility Testing (3 papers), RNA Research and Splicing (3 papers), Bioinformatics and Genomic Networks (3 papers), Pneumonia and Respiratory Infections (2 papers) and Respiratory viral infections research (2 papers). The work is most often cited by research in Cancer Research (750 citations), Aging (80 citations), Molecular Biology (2.1k citations), Genetics (409 citations) and Immunology (305 citations). Roy Navon has collaborated with scholars based in Israel, United States and Switzerland. Frequent co-authors include Zohar Yakhini, Israel Steinfeld, Eran Eden, Doron Lipson, Anya Tsalenko, Hui Wang, Amir Ben‐Dor, Anne‐Lise Børresen‐Dale, Espen Enerly and Merja Perälä. Their work appears in journals such as PLoS ONE, Open Forum Infectious Diseases, BMC Bioinformatics, Bioinformatics and Molecular Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact